Despite a considerable heterogeneity among the articles on which the meta-analysis was based compared to controls, MS patients were found to have significantly higher circulating leptin levels (SMD = 0.70, 95% CI 0.24 to 1.15, p < 0.001) [43]. This evidence concerns the gene LEP and myeloid sarcoma.